Work

Poster: MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf)

Year: 2021

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(21)01577-9

Authors: Evangelos Terpos, Ashraf Badros, Rakesh Popat, Paula Rodriguez-Otero, Asim Farooq, Bennie Jeng, Simona Degli Esposti, Eric Lewis, Ira Gupta, Joanna Opalinska, Antonio Palumbo, Suzanne Trudel

Institutions: National and Kapodistrian University of Athens, University of Maryland, Baltimore, University College London Hospitals NHS Foundation Trust, Navarre Institute of Health Research, Clinica Universidad de Navarra, University of Chicago Medical Center, Moorfields Eye Hospital NHS Foundation Trust, NIHR Moorfields Biomedical Research Centre, University College London, GlaxoSmithKline (United States), GlaxoSmithKline (Switzerland), Princess Margaret Cancer Centre

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4200456387

FWCI:

Cites:

Cited by:

Related to: 10